J&J | JNJ - Umsatzkosten





Umsatzkosten Veränderung Datum
AbbVie USD 4.29B 73M 2026-06
Abbott USD 5.94B 642M 2026-06
Amgen USD 1.87B 271M 2026-06
AstraZeneca USD 2.52B 2.73B 2026-06
Baxter International USD 1.93B 118M 2026-06
Bayer EUR 4.54B 692M 2026-06
Becton, Dickinson and Co. USD 2.67B 108M 2026-06
Biogen USD 945.1M 147.6M 2026-06
Boston Scientific USD 1.86B 29M 2026-06
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
CONMED USD 146.03M 12.43M 2026-06
Cooper Companies USD 393.8M 17M 2026-03
Dexcom USD 478.4M 36.8M 2026-06
Edwards Lifesciences USD 392.4M 29.8M 2026-06
Eli Lilly USD 3.27B 309M 2026-06
Gilead Sciences USD 1000M 445M 2026-06
GlaxoSmithKline GBP 2.07B 192M 2026-06
Globus Medical USD 271M 7.41M 2026-06
Insulet USD 239.1M 6.4M 2026-06
Integra LifeSciences USD 188.86M 10.15M 2026-06
Intuitive Surgical USD 931.9M 8.4M 2026-06
J&J USD 8B 67M 2026-06
Medtronic USD 3.83B 26M 2026-06
Merck USD 3.14B 200M 2026-06
Merit Medical Systems USD 203.68M 6.6M 2026-06
Novartis USD 3.71B 251M 2026-06
Pfizer USD 4.09B 498M 2026-06
Regeneron Pharmaceuticals USD 576.5M 92.9M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 3.02B 656M 2026-06
Stryker USD 2.26B 106M 2026-06
Tandem Diabetes Care USD 109.78M 653K 2026-06
Teva Pharmaceutical Industries USD 1.98B 30M 2026-06
Vertex Pharmaceuticals USD 489.2M 96.4M 2026-06
Zimmer Biomet Holdings USD 815.9M 77.6M 2026-06
Zoetis USD 704M 32M 2026-06